Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 54555
Gene Symbol: DDX49
DDX49
0.010 Biomarker disease BEFREE These findings suggested that DDX49 may be useful as a novel biomarker of lymph node metastases and therapeutic target for lung cancer metastasis. 31749282 2020
Entrez Id: 100313781
Gene Symbol: MIR718
MIR718
0.010 Biomarker disease BEFREE MicroRNA‑718 serves a tumor‑suppressive role in non‑small cell lung cancer by directly targeting CCNB1. 31746372 2020
Entrez Id: 23603
Gene Symbol: CORO1C
CORO1C
0.010 Biomarker disease BEFREE Coronin-3 (coronin-1C), a homotrimer F-actin-binding protein, has been reported to be important for metastasis in several types of cancers such as lung cancer, gastric cancer, and breast cancer. 31595425 2020
Entrez Id: 100188949
Gene Symbol: LINC00426
LINC00426
0.010 AlteredExpression disease BEFREE Bioinformatics analysis of LINC00426 expression in lung cancer and its correlation with patients' prognosis. 31691516 2020
Entrez Id: 644192
Gene Symbol: NR2F2-AS1
NR2F2-AS1
0.010 Biomarker disease BEFREE Long non-coding RNA (lncRNA) NR2F2 antisense RNA 1 (NR2F2-AS1) is an oncogenic lncRNA in lung cancer. 31432342 2020
Entrez Id: 4783
Gene Symbol: NFIL3
NFIL3
0.010 Biomarker disease BEFREE Accordingly, NFIL3 promoted lung cancer cell migration and invasion in a PrPc-dependent manner. 31477838 2020
Entrez Id: 693148
Gene Symbol: MIR563
MIR563
0.010 Biomarker disease BEFREE In this study, we aimed to provide clues to the function of miR-563 and its direct target in lung cancer. 31766078 2020
Entrez Id: 8535
Gene Symbol: CBX4
CBX4
0.010 Biomarker disease BEFREE However, the effect of CBX4 in the progression of lung cancer is not fully understood. 31724308 2020
Entrez Id: 58516
Gene Symbol: SINHCAF
SINHCAF
0.010 AlteredExpression disease BEFREE FAM60A has been found showing high levels in some cancer cells, including lung cancer (A549), and pancreatic cancer (Capan-2) cell lines. 31727367 2020
Entrez Id: 5886
Gene Symbol: RAD23A
RAD23A
0.010 Biomarker disease BEFREE HR23A-knockdown lung cancer cells exhibit epithelial-to-mesenchymal transition and gain stemness properties through increased Twist1 stability. 31487504 2019
Entrez Id: 693185
Gene Symbol: MIR600
MIR600
0.010 AlteredExpression disease BEFREE These data suggested that miR-600 inhibited lung cancer via down-regulating METTL3 expression, and knockdown of METTL3 might be used as a novel strategy for lung cancer therapy. 30774445 2019
Entrez Id: 4001
Gene Symbol: LMNB1
LMNB1
0.010 Biomarker disease BEFREE Thus, lamin B1 acts as a tumor suppressor in lung cancer, linking aberrant nuclear structure and epigenetic patterning with malignancy. 31015297 2019
Entrez Id: 5318
Gene Symbol: PKP2
PKP2
0.010 Biomarker disease BEFREE Subsequently, our results demonstrated that high PKP2 expression is not associated with poor survival in different gender of lung cancer patients, and is an unfavorable and independent prognostic biomarker for LUAD patients, but not for LUSC patients. 31126818 2019
Entrez Id: 4745
Gene Symbol: NELL1
NELL1
0.010 Biomarker disease BEFREE Our results suggest that NELL1 induces lung cancer stem‑like cell differentiation, which provides a new potential therapeutic target for cancer stem cells. 30628703 2019
Entrez Id: 5027
Gene Symbol: P2RX7
P2RX7
0.010 GeneticVariation disease BEFREE Moreover, the patients carrying GA and AA genotypes needed more fentanyl to control pain within 48 hours after surgery (P < .05 for all).P2RX7 gene rs1718125 polymorphism is significantly associated with postoperative pain and fentanyl consumption in patients with lung cancer. 30762755 2019
Entrez Id: 2027
Gene Symbol: ENO3
ENO3
0.010 Biomarker disease BEFREE These findings suggest that ENO3 -based targeted therapy might be promising for patients with lung cancer harboring <i>STK11</i> mutations. 31697874 2019
Entrez Id: 10953
Gene Symbol: TOMM34
TOMM34
0.010 AlteredExpression disease BEFREE Differential Expression of TOM34, AL1A1, PADI2 and KLRBA in NNK Induced Lung Cancer in Wistar Rats and their Implications. 31544692 2019
Entrez Id: 9575
Gene Symbol: CLOCK
CLOCK
0.010 Biomarker disease BEFREE Studies on clock genes may help to better understand the mechanism of lung cancer development for an improved treatment. 31014124 2019
Entrez Id: 5723
Gene Symbol: PSPH
PSPH
0.010 Biomarker disease BEFREE Phosphoserine Phosphatase Promotes Lung Cancer Progression through the Dephosphorylation of IRS-1 and a Noncanonical L-Serine-Independent Pathway. 31446747 2019
Entrez Id: 9949
Gene Symbol: AMMECR1
AMMECR1
0.010 Biomarker disease BEFREE The aim of this study was to characterize the role of Alport syndrome, mental retardation, midface hypoplasia, and elliptocytosis chromosomal region gene 1 (AMMECR1) in human lung cancer cell lines. 31519561 2019
Entrez Id: 4849
Gene Symbol: CNOT3
CNOT3
0.010 Biomarker disease BEFREE Taken together, our results reveal a role of CNOT3 in cisplatin resistance of lung cancer and provide a potential target for lung cancer therapy. 31177396 2019
Entrez Id: 100653365
Gene Symbol: BED
BED
0.010 AlteredExpression disease BEFREE These results indicate that Zbed3 may promote lung cancer cell proliferation through regulating PCNA expression besides regulating β-catenin expression and BED finger domain can impact on this function. 30805970 2019
Entrez Id: 102800311
Gene Symbol: TP53COR1
TP53COR1
0.010 AlteredExpression disease BEFREE An evident negative association between lincRNA‑p21 and miR‑17‑5p expression was observed, and the inhibitory effect of overexpressed lincRNA‑p21 on lung cancer cells was counteracted by miR‑17‑5p. 30535441 2019
Entrez Id: 145978
Gene Symbol: LINC00052
LINC00052
0.010 Biomarker disease BEFREE Some studies on the biological function of long intergenic non-protein-coding RNA 52 (LINC00052) in cancer indicate that this gene can act as either oncogene or tumor suppressor in some kinds of cancers, such as breast cancer, gastric cancer, liver cancer, and lung cancer. 31104316 2019
Entrez Id: 10653
Gene Symbol: SPINT2
SPINT2
0.010 AlteredExpression disease BEFREE Hepatocyte growth factor activator inhibitor-2 (HAI-2) was identified to be downregulated following lung cancer progression, which was related to poor survival and tumour invasion. 30765871 2019